Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

Journal of neurology, neurosurgery, and psychiatry
Published

The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts

Authors
Xuelin Tang, Vishaal Sumra, Christine Sato, Danielle Moreno, Mozhgan Khodadadi, Nusrat Sadia, Carmen Wong, Brenda Colella, Robin E A Green, Janet Ta, Kaj Blennow, Henrik Zetterberg, Richard Wennberg, Charles H Tator, Ming Zhang, Ekaterina Rogaeva, Maria Carmela Tartaglia
The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts
Journal of neurochemistry
Published

Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease

Authors
Tahmida Sharmin, James D Doecke, Pratishtha Chatterjee, Steve Pedrini, Hamid R Sohrabi, Nicholas J Ashton, Henrik Zetterberg, Manohar L Garg, Kaj Blennow, Ralph N Martins
Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease
Alzheimer's & dementia (Amsterdam, Netherlands)
Published

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS

Authors
Dustin B Hammers, Angelina Polsinelli, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Tatiana Foroud, Sujuan Gao, Laurel Beckett, Renaud La Joie, Alexandra Touroutoglou, Prashanthi Vemuri, Henrik Zetterberg, Kaj Blennow, Sára Nemes, Ralitsa Kostadinova, Paul Aisen, Kelly N Nudelman, Kala Kirby, Alireza Atri, David Clark, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Ian Grant, Lawrence S Honig, Erik C B Johnson, David T Jones, Joseph C Masdeu, Mario F Mendez, Leila Parand, Kyle Womack, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J Sha, Raymond Scott Turner, Thomas S Wingo, David A Wolk, Maria C Carrillo, Gil D Rabinovici, Bradford C Dickerson, Jeffrey L Dage, Liana G Apostolova, LEADS Consortium
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia

Zetterberg Lab